{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Insulin Resistance", "Management", "Medicinal plants", "Metabolic Syndrome", "Obesity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35673459", "DateRevised": {"Year": "2023", "Month": "03", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.1007/s40200-021-00965-2"], "Journal": {"ISSN": "2251-6581", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jun"}}, "Title": "Journal of diabetes and metabolic disorders", "ISOAbbreviation": "J Diabetes Metab Disord"}, "ArticleTitle": "Metabolic syndrome; Definition, Pathogenesis, Elements, and the Effects of medicinal plants on it's elements.", "Pagination": {"StartPage": "1011", "EndPage": "1022", "MedlinePgn": "1011-1022"}, "Abstract": {"AbstractText": ["Metabolic syndrome (MetS) is a cluster of metabolic risk factors that\u00a0include central obesity, hypertension, insulin resistance, and atherogenic dyslipidemia\u00a0and is strongly associated with a greater risk for developing cardiovascular disease\u00a0and type 2 diabetes mellitus.", "A literature search was conducted using the words metabolic syndrome,\u00a0definition and pathogenesis in Scopus, and PubMed. The search also extended to\u00a0cover medicinal plants and their role as a potential treatment of the metabolic\u00a0syndrome. The search based on studies published in the English language from 1st\u00a0of January 2000 to 30th of May 2021. The abstracts and the articles were then\u00a0screened. Articles were scanned and read; further relevant references in the reference\u00a0lists are also included.", "Both lifestyle factors and genetic factors are involved in the pathogenesis of\u00a0the metabolic syndrome. Recently, MetS have gained significant attention due to the\u00a0high prevalence of obesity worldwide. Diagnosis of patients with MetS is important to\u00a0improve the outcomes of the disease by employing lifestyle and risk factors\u00a0modifications. Currently, there is a rising interest in medicinal plants and their extracts\u00a0because the medicinal plants have minimal side effects. Here we review the history,\u00a0definitions, pathogenesis, management of metabolic syndrome and summarize the\u00a0beneficial effects of some medicinal plants and their extracts on MetS.", "Further research and clinical studies are needed to establish whether\u00a0medicinal plants can be safely given as potential therapy for metabolic syndrome and\u00a0whether this can be beneficial in low resources setting countries."], "CopyrightInformation": "\u00a9 Springer Nature Switzerland AG 2022, corrected publication 2022."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.444470.7", "0000 0000 8672 9927"], "Affiliation": "College of Medicine, Ajman University, P.O.Box: 346, Ajman, United Arab Emirates."}, {"Identifier": ["grid.444470.7", "0000 0000 8672 9927"], "Affiliation": "Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates."}], "LastName": "Ahmed", "ForeName": "Musaab", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.444470.7", "0000 0000 8672 9927"], "Affiliation": "College of Medicine, Ajman University, P.O.Box: 346, Ajman, United Arab Emirates."}, {"Identifier": ["grid.444470.7", "0000 0000 8672 9927"], "Affiliation": "Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates."}], "LastName": "Kumari", "ForeName": "Nisha", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.444470.7", "0000 0000 8672 9927"], "Affiliation": "College of Medicine, Ajman University, P.O.Box: 346, Ajman, United Arab Emirates."}, {"Identifier": ["grid.444470.7", "0000 0000 8672 9927"], "Affiliation": "Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates."}], "LastName": "Mirgani", "ForeName": "Zainelabdin", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.9763.b", "0000 0001 0674 6207"], "Affiliation": "Department of Physiology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan."}], "LastName": "Saeed", "ForeName": "Amal", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.444473.4", "0000 0004 1762 9411"], "Affiliation": "College of Pharmacy, Al-Ain University, Abu Dhabi, United Arab Emirates."}], "LastName": "Ramadan", "ForeName": "Azza", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.415667.7"], "Affiliation": "Department of Medicine and HIV metabolic Clinic, Milton Keynes University Hospital NHS Foundation Trust, Eaglestone, Milton Keynes, Buckinghamshire UK."}], "LastName": "Ahmed", "ForeName": "Mohamed H", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.461214.4", "0000 0004 0453 1968"], "Affiliation": "Department of Pathology, Faculty of Medicine, University of Medical Sciences and Technology, Khartoum, Sudan."}], "LastName": "Almobarak", "ForeName": "Ahmed Omer", "Initials": "AO"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Diabetes Metab Disord", "NlmUniqueID": "101590741", "ISSNLinking": "2251-6581"}, "CommentsCorrectionsList": [{"RefSource": "J Diabetes Metab Disord. 2022 May 3;21(1):1217. doi: 10.1007/s40200-022-01035-x", "PMID": "35675044"}], "CoiStatement": "Conflict of interestThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Grundy SM, Hansen B, Smith SC, Jr, Cleeman JI, Kahn RA, American Heart A, et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol. 2004;24(2):e19\u2013e24.", "ArticleIdList": ["14766740"]}, {"Citation": "Ahmed M, Ahmed MH. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World J Clin Cases. 2021;9(17):4133\u20134142. doi: 10.12998/wjcc.v9.i17.4133.", "ArticleIdList": ["10.12998/wjcc.v9.i17.4133", "PMC8173420", "34141776"]}, {"Citation": "Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, et al. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. Cell Metab. 2015;22(3):516\u2013530. doi: 10.1016/j.cmet.2015.07.007.", "ArticleIdList": ["10.1016/j.cmet.2015.07.007", "PMC4570502", "26299453"]}, {"Citation": "WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. 1999."}, {"Citation": "Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469\u2013480. doi: 10.1111/j.1464-5491.2006.01858.x.", "ArticleIdList": ["10.1111/j.1464-5491.2006.01858.x", "16681555"]}, {"Citation": "Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med. 1999;16(5):442\u2013443. doi: 10.1046/j.1464-5491.1999.00059.x.", "ArticleIdList": ["10.1046/j.1464-5491.1999.00059.x", "10342346"]}, {"Citation": "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.", "ArticleIdList": ["11368702"]}, {"Citation": "Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215\u2013225. doi: 10.1177/1753944717711379.", "ArticleIdList": ["10.1177/1753944717711379", "PMC5933580", "28639538"]}, {"Citation": "Gupta A, Gupta V. Metabolic syndrome: what are the risks for humans? Biosci Trends. 2010;4(5):204\u2013212.", "ArticleIdList": ["21068471"]}, {"Citation": "Arozal W, Louisa M, Soetikno V. Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies. Front Cardiovasc Med. 2020;7:82. doi: 10.3389/fcvm.2020.00082.", "ArticleIdList": ["10.3389/fcvm.2020.00082", "PMC7218133", "32435657"]}, {"Citation": "Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. African journal of traditional, complementary, and alternative medicines : AJTCAM. 2013;10(5):210\u2013229.", "ArticleIdList": ["PMC3847409", "24311829"]}, {"Citation": "Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013;13(1):7\u201312. doi: 10.7861/clinmedicine.13-1-7.", "ArticleIdList": ["10.7861/clinmedicine.13-1-7", "PMC5873713", "23472485"]}, {"Citation": "Joslin EP. The Outlook for the Diabetic. Cal West Med. 1927;26(2):177\u2013182.", "ArticleIdList": ["PMC1655364", "18740214"]}, {"Citation": "La VJ. differenciation sexuelle; facteur determinant des formes de l'obesite. Presse Med. 1947;55(30):339.", "ArticleIdList": ["18918084"]}, {"Citation": "Haller H. Epidermiology and associated risk factors of hyperlipoproteinemia. Z Gesamte Inn Med. 1977;32(8):124\u2013128.", "ArticleIdList": ["883354"]}, {"Citation": "Singer P. [Diagnosis of primary hyperlipoproteinemias]. Z Gesamte Inn Med. 1977;32(9):129-33 concl.", "ArticleIdList": ["906591"]}, {"Citation": "Phillips GB. Sex hormones, risk factors and cardiovascular disease. Am J Med. 1978;65(1):7\u201311. doi: 10.1016/0002-9343(78)90685-X.", "ArticleIdList": ["10.1016/0002-9343(78)90685-X", "356599"]}, {"Citation": "Phillips GB. Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci U S A. 1977;74(4):1729\u20131733. doi: 10.1073/pnas.74.4.1729.", "ArticleIdList": ["10.1073/pnas.74.4.1729", "PMC430867", "193114"]}, {"Citation": "Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595\u20131607. doi: 10.2337/diab.37.12.1595.", "ArticleIdList": ["10.2337/diab.37.12.1595", "3056758"]}, {"Citation": "Pouragha H, Amiri M, Saraei M, Pouryaghoub G, Mehrdad R. Body impedance analyzer and anthropometric indicators; predictors of metabolic syndrome. J Diabetes Metab Disord. 2021:1\u201310.", "ArticleIdList": ["PMC8275900", "34277496"]}, {"Citation": "Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA, Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis. Prev Med Rep. 2017;7:211\u2013215. doi: 10.1016/j.pmedr.2017.07.004.", "ArticleIdList": ["10.1016/j.pmedr.2017.07.004", "PMC5540707", "28794957"]}, {"Citation": "Feskens EJ, Tuomilehto J, Stengard JH, Pekkanen J, Nissinen A, Kromhout D. Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetologia. 1995;38(7):839\u2013847. doi: 10.1007/s001250050361.", "ArticleIdList": ["10.1007/s001250050361", "7556987"]}, {"Citation": "Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 1995;13(12 Pt 1):1457\u20131462.", "ArticleIdList": ["8866908"]}, {"Citation": "Lima NK, Abbasi F, Lamendola C, Reaven GM. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens. 2009;22(1):106\u2013111. doi: 10.1038/ajh.2008.263.", "ArticleIdList": ["10.1038/ajh.2008.263", "18772854"]}, {"Citation": "Utzschneider KM, Carr DB, Hull RL, Kodama K, Shofer JB, Retzlaff BM, et al. Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes. 2004;53(11):2867\u20132872. doi: 10.2337/diabetes.53.11.2867.", "ArticleIdList": ["10.2337/diabetes.53.11.2867", "15504967"]}, {"Citation": "Jiang J, Cai X, Pan Y, Du X, Zhu H, Yang X, et al. Relationship of obesity to adipose tissue insulin resistance. BMJ Open Diabetes Res Care. 2020;8(1).", "ArticleIdList": ["PMC7254100", "32245824"]}, {"Citation": "Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881\u2013887. doi: 10.1038/nature05488.", "ArticleIdList": ["10.1038/nature05488", "17167477"]}, {"Citation": "Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735\u20132752. doi: 10.1161/CIRCULATIONAHA.105.169404.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.105.169404", "16157765"]}, {"Citation": "Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629\u2013636. doi: 10.1161/ATVBAHA.107.151092.", "ArticleIdList": ["10.1161/ATVBAHA.107.151092", "18174459"]}, {"Citation": "Glosse P, Fajol A, Hirche F, Feger M, Voelkl J, Lang F, et al. A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFalpha upregulation. Nutr Diabetes. 2018;8(1):36. doi: 10.1038/s41387-018-0037-x.", "ArticleIdList": ["10.1038/s41387-018-0037-x", "PMC5972144", "29807981"]}, {"Citation": "Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, et al. Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS One. 2012;7(4):e34916. doi: 10.1371/journal.pone.0034916.", "ArticleIdList": ["10.1371/journal.pone.0034916", "PMC3325927", "22514690"]}, {"Citation": "Espinola-Klein C, Gori T, Blankenberg S, Munzel T. Inflammatory markers and cardiovascular risk in the metabolic syndrome. Front Biosci (Landmark Ed). 2011;16:1663\u20131674. doi: 10.2741/3812.", "ArticleIdList": ["10.2741/3812", "21196255"]}, {"Citation": "Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am. 2007;91(6):1063\u20131077. doi: 10.1016/j.mcna.2007.06.012.", "ArticleIdList": ["10.1016/j.mcna.2007.06.012", "17964909"]}, {"Citation": "Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237\u2013252.", "ArticleIdList": ["12924350"]}, {"Citation": "Ahren B, Pacini G. Islet adaptation to insulin resistance: mechanisms and implications for intervention. Diabetes Obes Metab. 2005;7(1):2\u20138. doi: 10.1111/j.1463-1326.2004.00361.x.", "ArticleIdList": ["10.1111/j.1463-1326.2004.00361.x", "15642070"]}, {"Citation": "Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039\u20131049. doi: 10.1161/ATVBAHA.107.159228.", "ArticleIdList": ["10.1161/ATVBAHA.107.159228", "18356555"]}, {"Citation": "Kobayashi K. Adipokines: therapeutic targets for metabolic syndrome. Curr Drug Targets. 2005;6(4):525\u2013529. doi: 10.2174/1389450054021972.", "ArticleIdList": ["10.2174/1389450054021972", "16026271"]}, {"Citation": "Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003;24(3):278\u2013301. doi: 10.1210/er.2002-0010.", "ArticleIdList": ["10.1210/er.2002-0010", "12788800"]}, {"Citation": "Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15(11):2792\u20132800. doi: 10.1097/01.ASN.0000141966.69934.21.", "ArticleIdList": ["10.1097/01.ASN.0000141966.69934.21", "15504932"]}, {"Citation": "Faerch K, Torekov SS, Vistisen D, Johansen NB, Witte DR, Jonsson A, et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes. 2015;64(7):2513\u20132525. doi: 10.2337/db14-1751.", "ArticleIdList": ["10.2337/db14-1751", "25677912"]}, {"Citation": "Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev. 1999;20(6):876\u2013913. doi: 10.1210/edrv.20.6.0385.", "ArticleIdList": ["10.1210/edrv.20.6.0385", "10605628"]}, {"Citation": "Brubaker PL, Drucker DJ. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology. 2004;145(6):2653\u20132659. doi: 10.1210/en.2004-0015.", "ArticleIdList": ["10.1210/en.2004-0015", "15044356"]}, {"Citation": "Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, et al. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 2006;4(5):391\u2013406. doi: 10.1016/j.cmet.2006.10.001.", "ArticleIdList": ["10.1016/j.cmet.2006.10.001", "17084712"]}, {"Citation": "Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, et al. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes. Pharmacol Rev. 2016;68(4):954\u20131013. doi: 10.1124/pr.115.011395.", "ArticleIdList": ["10.1124/pr.115.011395", "PMC5050443", "27630114"]}, {"Citation": "Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, et al. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab. 2001;86(8):3717\u20133723. doi: 10.1210/jcem.86.8.7750.", "ArticleIdList": ["10.1210/jcem.86.8.7750", "11502801"]}, {"Citation": "Bodnaruc AM, Prud'homme D, Blanchet R, Giroux I. Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review. Nutr Metab (Lond). 2016;13:92. doi: 10.1186/s12986-016-0153-3.", "ArticleIdList": ["10.1186/s12986-016-0153-3", "PMC5148911", "27990172"]}, {"Citation": "Seon MJ, Hwang SY, Son Y, Song J, Kim OY. Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women. Nutrients. 2021;13(3).", "ArticleIdList": ["PMC8001839", "33800785"]}, {"Citation": "de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97\u2013105. doi: 10.1016/j.febslet.2007.11.057.", "ArticleIdList": ["10.1016/j.febslet.2007.11.057", "PMC2246086", "18053812"]}, {"Citation": "Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994;91(11):4854\u20134858. doi: 10.1073/pnas.91.11.4854.", "ArticleIdList": ["10.1073/pnas.91.11.4854", "PMC43887", "8197147"]}, {"Citation": "Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism. 1999;48(10):1332\u20131335. doi: 10.1016/S0026-0495(99)90277-9.", "ArticleIdList": ["10.1016/S0026-0495(99)90277-9", "10535400"]}, {"Citation": "Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, et al. Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012;126(23):2739\u20132748. doi: 10.1161/CIRCULATIONAHA.112.122556.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.112.122556", "23129601"]}, {"Citation": "Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356(15):1517\u20131526. doi: 10.1056/NEJMoa065213.", "ArticleIdList": ["10.1056/NEJMoa065213", "17429083"]}, {"Citation": "Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391\u2013397. doi: 10.1161/01.CIR.0000055014.62083.05.", "ArticleIdList": ["10.1161/01.CIR.0000055014.62083.05", "12551861"]}, {"Citation": "Popovic M, Ebrahimi F, Urwyler SA, Donath MY, Christ-Crain M. The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome. Endocr Connect. 2020;9(7):715\u2013723. doi: 10.1530/EC-20-0197.", "ArticleIdList": ["10.1530/EC-20-0197", "PMC7424357", "32698151"]}, {"Citation": "Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract. 2006;71(1):92\u2013100. doi: 10.1016/j.diabres.2005.05.003.", "ArticleIdList": ["10.1016/j.diabres.2005.05.003", "16002176"]}, {"Citation": "Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13(1):9\u201319.", "ArticleIdList": ["PMC2633261", "19240815"]}, {"Citation": "Gupta Jain S, Puri S, Misra A, Gulati S, Mani K. Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double -blind control trial. Lipids Health Dis. 2017;16(1):113. doi: 10.1186/s12944-017-0504-8.", "ArticleIdList": ["10.1186/s12944-017-0504-8", "PMC5469078", "28606084"]}, {"Citation": "Cao H, Graves DJ, Anderson RA. Cinnamon extract regulates glucose transporter and insulin-signaling gene expression in mouse adipocytes. Phytomedicine. 2010;17(13):1027\u20131032. doi: 10.1016/j.phymed.2010.03.023.", "ArticleIdList": ["10.1016/j.phymed.2010.03.023", "20554184"]}, {"Citation": "Birem Z, Tabani K, Lahfa F, Djaziri R, Hadjbekkouche F, Koceir EA, et al. Effects of colocynth alkaloids and glycosides on Wistar rats fed high-fat diet. A biochemical and morphological study. Folia Histochem Cytobiol. 2017;55(2):74\u201385. doi: 10.5603/FHC.a2017.0011.", "ArticleIdList": ["10.5603/FHC.a2017.0011", "28691730"]}, {"Citation": "Marzouk B, Marzouk Z, Fenina N, Bouraoui A, Aouni M. Anti-inflammatory and analgesic activities of Tunisian Citrullus colocynthis Schrad. immature fruit and seed organic extracts. Eur Rev Med Pharmacol Sci. 2011;15(6):665\u2013672.", "ArticleIdList": ["21796871"]}, {"Citation": "Abdel-Hassan IA, Abdel-Barry JA, Tariq MS. The hypoglycaemic and antihyperglycaemic effect of citrullus colocynthis fruit aqueous extract in normal and alloxan diabetic rabbits. J Ethnopharmacol. 2000;71(1-2):325\u2013330. doi: 10.1016/S0378-8741(99)00215-9.", "ArticleIdList": ["10.1016/S0378-8741(99)00215-9", "10904181"]}, {"Citation": "Rahbar AR, Nabipour I. The hypolipidemic effect of Citrullus colocynthis on patients with hyperlipidemia. Pak J Biol Sci. 2010;13(24):1202\u20131207. doi: 10.3923/pjbs.2010.1202.1207.", "ArticleIdList": ["10.3923/pjbs.2010.1202.1207", "21313901"]}, {"Citation": "Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;2(4):320\u2013330. doi: 10.1016/S2221-1691(12)60032-X.", "ArticleIdList": ["10.1016/S2221-1691(12)60032-X", "PMC3609288", "23569923"]}, {"Citation": "Tabani K, Birem Z, Halzoune H, Saiah W, Lahfa F, Koceir EA, et al. Therapeutic effect of alkaloids and glycosides of colocynth seeds on liver injury, associated with metabolic syndrome in wistar rats, subject to nutritional stress. Pak J Pharm Sci. 2018;31(1(Suppl.)):277-90.", "ArticleIdList": ["29386155"]}, {"Citation": "Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem. 2005;53(4):959\u2013963. doi: 10.1021/jf0483873.", "ArticleIdList": ["10.1021/jf0483873", "15713005"]}, {"Citation": "Younas A, Naqvi SA, Khan MR, Shabbir MA, Jatoi MA, Anwar F, et al. Functional food and nutra-pharmaceutical perspectives of date (Phoenix dactylifera L.) fruit. J Food Biochem. 2020:e13332.", "ArticleIdList": ["32588917"]}, {"Citation": "Al-Alawi RA, Al-Mashiqri JH, Al-Nadabi JSM, Al-Shihi BI, Baqi Y. Date Palm Tree (Phoenix dactylifera L.): Natural Products and Therapeutic Options. Front. Plant Sci. 2017;8:845.", "ArticleIdList": ["PMC5440559", "28588600"]}, {"Citation": "Khan TJ, Kuerban A, Razvi SS, Mehanna MG, Khan KA, Almulaiky YQ, et al. In vivo evaluation of hypolipidemic and antioxidative effect of 'Ajwa' (Phoenix dactylifera L.) date seed-extract in high-fat diet-induced hyperlipidemic rat model. Biomed Pharmacother. 2018;107:675\u2013680. doi: 10.1016/j.biopha.2018.07.134.", "ArticleIdList": ["10.1016/j.biopha.2018.07.134", "30125841"]}, {"Citation": "Al-Yahya M, Raish M, AlSaid MS, Ahmad A, Mothana RA, Al-Sohaibani M, et al. 'Ajwa' dates (Phoenix dactylifera L.) extract ameliorates isoproterenol-induced cardiomyopathy through downregulation of oxidative, inflammatory and apoptotic molecules in rodent model. Phytomedicine. 2016;23(11):1240\u20131248. doi: 10.1016/j.phymed.2015.10.019.", "ArticleIdList": ["10.1016/j.phymed.2015.10.019", "26776662"]}, {"Citation": "Aboshora W, Yu J, Omar KA, Li Y, Hassanin HAM, Navicha WB, et al. Preparation of Doum fruit (Hyphaene thebaica) dietary fiber supplemented biscuits: influence on dough characteristics, biscuits quality, nutritional profile and antioxidant properties. J Food Sci Technol. 2019;56(3):1328\u20131336. doi: 10.1007/s13197-019-03605-z.", "ArticleIdList": ["10.1007/s13197-019-03605-z", "PMC6423248", "30956312"]}, {"Citation": "Salib JY, Michael HN, Eskande EF. Antidiabetic properties of flavonoid compounds isolated from Hyphaene thebaica epicarp on alloxan induced diabetic rats. Pharmacognosy Res. 2013;5(1):22\u201329. doi: 10.4103/0974-8490.105644.", "ArticleIdList": ["10.4103/0974-8490.105644", "PMC3579016", "23598921"]}, {"Citation": "Perez-Torres I, Torres-Narvaez JC, Pedraza-Chaverri J, Rubio-Ruiz ME, Diaz-Diaz E, Del Valle-Mondragon L, et al. Effect of the Aged Garlic Extract on Cardiovascular Function in Metabolic Syndrome Rats. Molecules. 2016;21(11).", "ArticleIdList": ["PMC6273338", "27792195"]}, {"Citation": "Padiya R, Khatua TN, Bagul PK, Kuncha M, Banerjee SK. Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats. Nutr Metab (Lond). 2011;8:53. doi: 10.1186/1743-7075-8-53.", "ArticleIdList": ["10.1186/1743-7075-8-53", "PMC3168415", "21794123"]}, {"Citation": "Choudhary PR, Jani RD, Sharma MS. Effect of Raw Crushed Garlic (Allium sativum L.) on Components of Metabolic Syndrome. J Diet Suppl. 2018;15(4):499\u2013506. doi: 10.1080/19390211.2017.1358233.", "ArticleIdList": ["10.1080/19390211.2017.1358233", "28956671"]}, {"Citation": "Gomez-Arbelaez D, Lahera V, Oubina P, Valero-Munoz M, de Las HN, Rodriguez Y, et al. Aged garlic extract improves adiponectin levels in subjects with metabolic syndrome: a double-blind, placebo-controlled, randomized, crossover study. Mediators Inflamm. 2013;2013:285795. doi: 10.1155/2013/285795.", "ArticleIdList": ["10.1155/2013/285795", "PMC3603419", "23533302"]}, {"Citation": "Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296(10):1255\u20131265. doi: 10.1001/jama.296.10.1255.", "ArticleIdList": ["10.1001/jama.296.10.1255", "16968850"]}, {"Citation": "Mousavi A, Vafa M, Neyestani T, Khamseh M, Hoseini F. The effects of green tea consumption on metabolic and anthropometric indices in patients with Type 2 diabetes. J Res Med Sci. 2013;18(12):1080\u20131086.", "ArticleIdList": ["PMC3908530", "24523800"]}, {"Citation": "Razavi BM, Lookian F, Hosseinzadeh H. Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats. Biomed Pharmacother. 2017;92:726\u2013731. doi: 10.1016/j.biopha.2017.05.113.", "ArticleIdList": ["10.1016/j.biopha.2017.05.113", "28586744"]}, {"Citation": "Zhang Y, Gu M, Wang R, Li M, Li D, Xie Z. Dietary supplement of Yunkang 10 green tea and treadmill exercise ameliorate high fat diet induced metabolic syndrome of C57BL/6 J mice. Nutr Metab (Lond). 2020;17:14. doi: 10.1186/s12986-020-0433-9.", "ArticleIdList": ["10.1186/s12986-020-0433-9", "PMC7001212", "32042300"]}, {"Citation": "Nasir O. Renal and extrarenal effects of gum arabic ( Acacia senegal )--what can be learned from animal experiments? Kidney Blood Press Res. 2013;37(4-5):269\u2013279. doi: 10.1159/000350152.", "ArticleIdList": ["10.1159/000350152", "24022265"]}, {"Citation": "Babiker R, Elmusharaf K, Keogh MB, Saeed AM. Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial. Lipids Health Dis. 2018;17(1):56. doi: 10.1186/s12944-018-0711-y.", "ArticleIdList": ["10.1186/s12944-018-0711-y", "PMC5859434", "29558953"]}, {"Citation": "Nasir O, Artunc F, Wang K, Rexhepaj R, Foller M, Ebrahim A, et al. Downregulation of mouse intestinal Na(+)-coupled glucose transporter SGLT1 by gum arabic (Acacia Senegal) Cell Physiol Biochem. 2010;25(2-3):203\u2013210. doi: 10.1159/000276554.", "ArticleIdList": ["10.1159/000276554", "20110681"]}, {"Citation": "Sayago-Ayerdi SG, Arranz S, Serrano J, Goni I. Dietary fiber content and associated antioxidant compounds in Roselle flower (Hibiscus sabdariffa L.) beverage. J Agric Food Chem. 2007;55(19):7886\u20137890. doi: 10.1021/jf070485b.", "ArticleIdList": ["10.1021/jf070485b", "17705439"]}, {"Citation": "Chen CC, Hsu JD, Wang SF, Chiang HC, Yang MY, Kao ES, et al. Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits. J Agric Food Chem. 2003;51(18):5472\u20135477. doi: 10.1021/jf030065w.", "ArticleIdList": ["10.1021/jf030065w", "12926900"]}, {"Citation": "Wang SC, Lee SF, Wang CJ, Lee CH, Lee WC, Lee HJ. Aqueous Extract from Hibiscus sabdariffa Linnaeus Ameliorate Diabetic Nephropathy via Regulating Oxidative Status and Akt/Bad/14-3-3gamma in an Experimental Animal Model. Evid Based Complement Alternat Med. 2011;2011:938126.", "ArticleIdList": ["PMC3139510", "19965962"]}, {"Citation": "Diez-Echave P, Vezza T, Rodriguez-Nogales A, Ruiz-Malagon AJ, Hidalgo-Garcia L, Garrido-Mesa J, et al. The prebiotic properties of Hibiscus sabdariffa extract contribute to the beneficial effects in diet-induced obesity in mice. Food Res Int. 2020;127:108722. doi: 10.1016/j.foodres.2019.108722.", "ArticleIdList": ["10.1016/j.foodres.2019.108722", "31882094"]}, {"Citation": "Aizat WM, Jamil IN, Ahmad-Hashim FH, Noor NM. Recent updates on metabolite composition and medicinal benefits of mangosteen plant. PeerJ. 2019;7:e6324. doi: 10.7717/peerj.6324.", "ArticleIdList": ["10.7717/peerj.6324", "PMC6368837", "30755827"]}, {"Citation": "Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol. 2008;46(2):688\u2013693. doi: 10.1016/j.fct.2007.09.096.", "ArticleIdList": ["10.1016/j.fct.2007.09.096", "18029076"]}, {"Citation": "Cho BO, Ryu HW, So Y, Lee CW, Jin CH, Yook HS, et al. Anti-Inflammatory Effect of Mangostenone F in Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Suppressing NF-kappaB and MAPK Activation. Biomol Ther (Seoul). 2014;22(4):288\u2013294. doi: 10.4062/biomolther.2014.052.", "ArticleIdList": ["10.4062/biomolther.2014.052", "PMC4131528", "25143806"]}, {"Citation": "Chae HS, Kim YM, Bae JK, Sorchhann S, Yim S, Han L, et al. Mangosteen Extract Attenuates the Metabolic Disorders of High-Fat-Fed Mice by Activating AMPK. J Med Food. 2016;19(2):148\u2013154. doi: 10.1089/jmf.2015.3496.", "ArticleIdList": ["10.1089/jmf.2015.3496", "26452017"]}, {"Citation": "Watanabe M, Gangitano E, Francomano D, Addessi E, Toscano R, Costantini D, et al. Mangosteen Extract Shows a Potent Insulin Sensitizing Effect in Obese Female Patients: A Prospective Randomized Controlled Pilot Study. Nutrients. 2018;10(5).", "ArticleIdList": ["PMC5986466", "29747432"]}, {"Citation": "Bhat M, Kothiwale SK, Tirmale AR, Bhargava SY, Joshi BN. Antidiabetic Properties of Azardiracta indica and Bougainvillea spectabilis: In Vivo Studies in Murine Diabetes Model. Evid Based Complement Alternat Med. 2011;2011:561625.", "ArticleIdList": ["PMC3136679", "19389871"]}, {"Citation": "Mohtashami A. Effects of Bread with Nigella Sativa on Blood Glucose, Blood Pressure and Anthropometric Indices in Patients with Metabolic Syndrome. Clin Nutr Res. 2019;8(2):138\u2013147. doi: 10.7762/cnr.2019.8.2.138.", "ArticleIdList": ["10.7762/cnr.2019.8.2.138", "PMC6494753", "31089467"]}, {"Citation": "Shirazi M, Khodakarami F, Feizabad E, Ghaemi M. The effects of nigella sativa on anthropometric and biochemical indices in postmenopausal women with metabolic syndrome. Endocrine. 2020;69(1):49\u201352. doi: 10.1007/s12020-020-02265-w.", "ArticleIdList": ["10.1007/s12020-020-02265-w", "32236818"]}, {"Citation": "Bordoni L, Fedeli D, Fiorini D, Gabbianelli R. Extra Virgin Olive Oil and Nigella sativa Oil Produced in Central Italy: A Comparison of the Nutrigenomic Effects of Two Mediterranean Oils in a Low-Grade Inflammation Model. Antioxidants (Basel). 2019;9(1).", "ArticleIdList": ["PMC7022781", "31878334"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "1"}, {"Year": "2021", "Month": "12", "Day": "23"}, {"Year": "2022", "Month": "6", "Day": "8", "Hour": "1", "Minute": "57"}, {"Year": "2022", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "3", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35673459", "PMC9167315", "10.1007/s40200-021-00965-2", "965"]}}], "PubmedBookArticle": []}